Impact of the Mass Drug Administration for malaria in response to the Ebola outbreak in Sierra Leone

Malaria Journal

Volumn 15, Issue 1, 2016, Pages

  Aregawi, Maru ^a   Smith, Samuel J ^b   Sillah Kanu, Musa ^b   Seppeh, John ^b   Kamara, Anitta R Y ^b   Williams, Ryan O ^a   Aponte, John J ^c   Bosman, Andrea ^a   Alonso, Pedro ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b Ministry of Health and Sanitation (MoHS)   (Sierra Leone)

^c CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE PLUS ARTESUNATE; AMODIAQUINE; AMODIAQUINE, ARTESUNATE DRUG COMBINATION; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; DRUG COMBINATION;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE TRANSMISSION; EBOLA HEMORRHAGIC FEVER; EPIDEMIC; GOVERNMENT REGULATION; HEALTH CARE DELIVERY; HEALTH CARE DISTRIBUTION; HOSPITAL INFECTION; HUMAN; INFANT; INFECTION CONTROL; INFECTION RISK; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; MALARIA RAPID TEST; MASS DRUG ADMINISTRATION; MORBIDITY; OUTPATIENT; PUBLIC HEALTH; SIERRA LEONE; TIME SERIES ANALYSIS; ADULT; AGED; DRUG COMBINATION; FEMALE; HEALTH SERVICES RESEARCH; HEMORRHAGIC FEVER, EBOLA; MALE; MIDDLE AGED; PRESCHOOL CHILD; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMODIAQUINE; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; DRUG COMBINATIONS; FEMALE; HEALTH SERVICES RESEARCH; HEMORRHAGIC FEVER, EBOLA; HUMANS; INFANT; MALARIA; MALE; MIDDLE AGED; SIERRA LEONE; YOUNG ADULT;

EID: 84988674521     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-016-1493-1     Document Type: Article

References (21)

1. United Nations Populations prospects. 2015. http://esa.un.org/unpd/wpp/publications/files/key-findings-wpp-2015.pdf. Accessed 04 Dec 2015.
2. Sierra Leone Malaria Indicator Survey 2013. National Malaria Control Programme (NMCP) [Sierra Leone] Statistics Sierra Leone University of Sierra Leone Catholic Relief Services and ICF International. Freetown, Sierra Leone: NMCP, SSL, CRS, and ICF International; 2013.
3. Sierra Leone demographic and health survey 2013. Statistics Sierra Leone (SSL) and ICF International. Sierra Leone: SSL and ICF International; 2014.
4. WHO. World malaria report 2014. Geneva: World Health Organization; 2014; http://www.who.int/malaria/publications/world-malaria-report-2014/en/. Accessed 23 June 2015.
5. Ministry of Health and Sanitation, Sierra Leone (MoHS). 2015. http://health.gov.sl/wp-content/uploads/2015/08/Ebola-Update-August-12-2015.pdf. Accessed 03 Nov 2015.
6. Ministry of Health and Sanitation. Sierra Leone (MoHS). Sierra Leone: Health Facility; 2014.
7. Walker PG, White MT, Griffin JT, Reynolds A, Ferguson NM, Ghani AC. Malaria morbidity and mortality in Ebola-affected countries caused by decreased health-care capacity and the potential effect of mitigation strategies: a modelling analysis. Lancet Infect Dis. 2015;15:825-32.
8. Plucinski MM, Guilavogui T, Sidikiba S, Diakité N, Diakité S, Dioubaté M, et al. Effect of the Ebola-virus-disease epidemic on malaria case management in Guinea 2014: a cross-sectional survey of health facilities. Lancet Infect Dis. 2015;15:1017-23.
9. WHO. Guidance on temporary malaria control measures in Ebola-affected countries. Geneva: World Health Organization; 2014. http://www.who.int/malaria/publications/atoz/malariacontrol-ebola-affected-countries/en/. Accessed 23 June 2015.
10. Ministry of Health and Sanitation. LLIN Mass Campaign report 2014. National Malaria Control Programme; 2014.
11. WHO. Case definition recommendations for Ebola or Marburg virus diseases. Geneva: World Health Organization; 2014. http://apps.who.int/iris/bitstream/10665/146397/1/WHO-EVD-CaseDef-14.1-eng.pdf?ua=1&ua=1. Accessed 09 Aug 2014.
12. Stata Corporation. 2015. http://www.stata.com/new-in-stata/. Accessed 23 Nov 2015.
13. Zhang F, Wagner AK, Soumerai SB, Ross-Degnan D. Methods for estimating confidence intervals in interrupted time series analyses of health interventions. J Clin Epidemiol. 2009;62:143-8.
14. Ministry of Health and Sanitation, Sierra Leone. Report of the Independent Monitors of the Malaria Mass Drug Administration for Artesunate Amodiaquine (ASAQ). Sierra Leone: Ministry of Health and Sanitation; 2015.
15. Ministry of Health and Sanitation, Sierra Leone. Report on adverse drug reaction (ADA) of the ASAQ used for the Malaria Mass Drug Administration Pharmacovigilance Team Board of Pharmacy and MoHS. Sierra Leone; 2015.
16. Ministry of Health and Sanitation, Sierra Leone. Results of the Mass Drug Administration (MDA) in response to the Ebola outbreak, December to. National Malaria Control Programme. Sierra Leone: Ministry of Health and Sanitation; 2015.
17. World Health Organization. Guidelines for treatment of malaria. 3rd ed. Geneva: World Health Organization; 2015. p. 205-6.
18. Checchi F, Roddy P, Kamara S, Williams A, Morineau G, Wurie AR, et al. Evidence basis for antimalarial policy change in Sierra Leone: five in vivo efficacy studies of chloroquine, sulphadoxine-pyrimethamine and amodiaquine. Trop Med Int Health. 2005;10:146-53.
19. Molineaux L, Storey J, Cohen JE, Thomas A. A longitudinal study of human malaria in the West African Savanna in the absence of control measures: relationships between different Plasmodium species in particular P. falciparum and P. malariae. Am J Trop Med Hyg. 1980;29:725-37.
20. Medecins Sans Frontieres (MSF). Report on performance and time to become negative of three malaria rapid diagnostic tests for in children under 5 years of age. Evaluation in two different malaria epidemiological settings in Greater Mbarara district, Uganda; 2012-13.
21. Hopkins H, Bebell L, Kambale W, Dokomajilar C, Rosenthal PJ, Dorsey G. Rapid diagnostic tests for malaria at sites of varying transmission intensity in Uganda. J Infect Dis. 2008;197:510-8.